Comparison of Stent Graft, Sirolimus Stent, and Bare Metal Stent Implanted in Patients with Acute Coronary Syndrome: Clinical and Angiographic Follow-up

Strozzi, Maja; Anić, Darko
June 2007
Croatian Medical Journal;2007, Vol. 48 Issue 3, p348
Academic Journal
No abstract available.


Related Articles

  • Sirolimus-Eluting Stents for Treatment of In-Stent Restenosis. Medina, Alfonso; De Lezo, José Suárez; Pan, Manuel; Delgado, Antonio; Segura, José; Pavlovic, Djordje; Melián, Francisco; Romero, Miguel; Segura, Federico; Hernández, Enrique; Ureña, Isabel; Herrador, Juan // Texas Heart Institute Journal;2005, Vol. 32 Issue 1, p11 

    We analyzed the clinical, angiographic, and late intravascular ultrasonographic findings from 140 patients whose in-stent restenosis was treated with sirolimus-eluting stents. In-stent restenosis remains the main limitation to percutaneous coronary revascularization and has a high recurrence...

  • Drug-Eluting Stents in Daily Practice: Is There a Difference Between Sirolimus- and Paclitaxel-Eluting Stents? Goy, Jean-Jacques // Current Medical Literature: Interventional Cardiology Monitor;2005, Vol. 12 Issue 4, p85 

    The article presents information about the drug-eluting stents (DESs). The outcome of percutaneous coronary intervention has been significantly improved with the use of stents. Major advances have been made in the fields of angioplasty and stenting. But, in-stent restenosis remains a major...

  • Sirolimus Eluting Stents. Hu, Patrick P.; Mahmud, Ehtisham // Clinical Medicine Insights: Therapeutics;2010, Issue 2, p549 

    The sirolimus-eluting stent (SES) Cypher was the first commercially available drug-eluting stent. The use of this stent has resulted in significantly lower rates of restenosis and lesion revascularization compared to bare metal stents and balloon angioplasty. In this review, angiographic and...

  • Drug-coated stent marks new era in interventional cardiology. Hitchens, Kathy // Drug Topics;6/16/2003, Vol. 147 Issue 12, DRUG TOPICS... p3 

    Features the Cypher, a sirolimus-eluting stent for patients with coronary artery disease in the U.S. Reduction of sustained reblockage rate; Comparison with bare metal stent; Risk for stenosis.

  • Perioperatives Management von Patienten mit Koronarstents bei nichtherzchirurgischen Eingriffen. Jämbor, C.; Spannagl, M.; Zwissler, B. // Anaesthesist;Oct2009, Vol. 58 Issue 10, p971 

    In patients with coronary stents scheduled for surgery the question arises whether and how antiplatelet therapy should be continued. Risks of perioperative bleeding and of acute stent thrombosis have to be considered simultaneously. The bleeding risk depends primarily on the kind of surgery and...

  • Comparison of a drug-eluting balloon first and then bare metal stent with a drug-eluting stent for treatment of de novo lesions: study protocol of a randomized controlled trial. Park, Sang-Don; Yoon, Chang-Hwan; Oh, Il-Young; Suh, Jung-Won; Cho, Young-Suk; Youn, Tae-Jin; Choi, Dong-Ju; Chae, In-Ho // Trials;2013, Vol. 14 Issue 1, p1 

    Background: The use of a drug-eluting balloon for the treatment of de novo coronary artery lesions remains to be evaluated. A previous trial in patients with stable and unstable angina comparing a bare metal stent mounted on a drug-eluting balloon with a sirolimus-eluting stent failed to meet...

  • Sirolimus-eluting stents "reasonably" cost effective in the US.  // PharmacoEconomics & Outcomes News;9/11/2004, Issue 461, p9 

    Discusses research being done on the cost effectiveness of sirolimus-eluting stents in patients undergoing percutaneous coronary intervention. Reference to a study by D. J. Cohen et al, published in the August 3, 2004 issue of "Circulation"; Comparison of the cost effectiveness of conventional...

  • Sirolimus-eluting Stents for Restenosis of Bare-metal Stents. Boyle, Andrew J. // Clinical Cardiology Alert;Apr2010, Vol. 29 Issue 4, p27 

    The article discusses research on the use of sirolimus-eluting stents (SES) for bare-metal stent (BMS) restenosis. It references the study "Long-Term Effectiveness and Safety of Sirolimus Stent Implantation for Coronary In-Stent Restenosis. Results of the TRUE (Tuscany Registry of Sirolimus for...

  • A cockscomb-like aneurysm of the right coronary artery after bare metal stent implantation. Kalkan, Mehmet Emin; Açar, Göksel; Tabakcı, Mehmet Mustafa; Demir, Serdar; Sahin, Müslüm; Akçakoyun, Mustafa // Advances in Interventional Cardiology;2014, Vol. 10 Issue 1, p50 

    Coronary artery aneurysm (CAA) formation is an uncommon but potentially life-threatening event after coronary balloon angioplasty or stent implantation. In this report, we present a case of a patient who had a cockscomb-like aneurysm after bare metal stent implantation which was successfully...

  • In-hospital and mid-term clinical outcomes after percutaneous coronary intervention with drug eluting stents. Pai, D. Narasimha; Madi, Deepak R.; Achappa, Basavaprabhu; Unnikrishnan, B. // International Journal of Biological & Medical Research;Aug2012, Vol. 3 Issue 4, p2527 

    Background and objective-Sirolimus-eluting (SES) and paclitaxel-eluting (PES) stents are first generation drug-eluting stents (DES) used to treat patients with ischemic heart disease. Drugeluting stents (DES) have reduced the occurrence of restenosis and major adverse cardiac events (MACE) when...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics